Prelude Therapeutics Incorporated
SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5)
Last updated:
Abstract:
The disclosure is directed to compounds of Formula I ##STR00001## Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.
Status:
Application
Type:
Utility
Filling date:
1 Jun 2020
Issue date:
17 Sep 2020